Haitian Antenna (08227) disclosed that its net loss attributable to shareholders in 2025 is approximately 8.7124 million yuan, a year-on-year decrease of 45.14%.

19:03 31/03/2026

Hai Tian Antenna (08227) announced its performance in 2025, with total operating revenue of approximately 27.5783 million yuan, an increase of 25.58% compared to the previous year; the net loss attributable to owners of the parent company is approximately 8.7124 million yuan, a decrease of 45.14% year-on-year; basic loss per share is 0.0046 yuan.

HaiTian Airlines (08227) announced its performance in 2025, with a total operating income of approximately 27.5783 million yuan, a year-on-year increase of 25.58%; net loss attributable to the owners of the parent company was approximately 8.7124 million yuan, a year-on-year decrease of 45.14%; basic loss per share was 0.0046 yuan.

Withdraw application! Xinyi Technology's Shanghai Stock Exchange IPO process hits "terminate" button.

HONY MEDIA (00419) announced its performance for 2025, with shareholders' equity losses amounting to HK$66.717 million, narrowing by 59.19% year-on-year.

ABBISKO-B(02256):FGFR4 inhibitor infigratinib granted orphan drug designation by EMA for the treatment of hepatocellular carcinoma.

Withdraw application! Xinyi Technology's Shanghai Stock Exchange IPO process hits "terminate" button.

HONY MEDIA (00419) announced its performance for 2025, with shareholders' equity losses amounting to HK$66.717 million, narrowing by 59.19% year-on-year.

ABBISKO-B(02256):FGFR4 inhibitor infigratinib granted orphan drug designation by EMA for the treatment of hepatocellular carcinoma.